Boston-based CorticoMetrics announces that it has received 510(k) clearance from the U.S. FDA for THINQ, an artificial intelligence-based software for use by radiologists and neurologists providing quantitative information to augment patient assessment for a number of neurological disorders and conditions.
THINQ automatically segments a T1-weighted MRI brain image, reporting volumetric measurements and visualizations of 30 critical brain structures, and compares these measures to age and gender-matched reference percentile data. Reporting includes images of the brain with color-coded segmentations, as well as plots showing how measurements compare to reference data. The brain segmentations are also available in DICOM format as encapsulated JPEG images.
Nick Schmansky, co-founder and CEO of CorticoMetrics, believes this product will have strong implications for the radiologic industry. Specifically, he says, “THINQ reporting aids the workflow of radiologists and neurologists, aiming to increase examination throughput and improve the overall quality of patient outcomes.”
